Gut Microbiome & Neurodegeneration

Patients with neurodegenerative diseases often have an altered composition of the gut microbiome. Novel reports suggest that there is an extensive crosstalk between the gut microbiome and the brain, and this may influence neurodegeneration. Discover the latest research on how the gut microbiome influences neurodegeneration here.

November 18, 2020
Open Access

A meta-analysis of the effect of binge drinking on the oral microbiome and its relation to Alzheimer's disease

Scientific Reports
Ayuni YussofSulie L Chang
November 22, 2020
Review
Open Access

You Talking to Me? Says the Enteric Nervous System (ENS) to the Microbe. How Intestinal Microbes Interact with the ENS

Journal of Clinical Medicine
Mauro GiuffrèLory Saveria Crocè
November 21, 2020
Open Access

Oral P. gingivalis impairs gut permeability and mediates immune responses associated with neurodegeneration in LRRK2 R1441G mice

Journal of Neuroinflammation
Yu-Kun FengZhong Pei
November 22, 2020
Open Access

The Differences between Gluten Sensitivity, Intestinal Biomarkers and Immune Biomarkers in Patients with First-Episode and Chronic Schizophrenia

Journal of Clinical Medicine
Michał DzikowskiHanna Karakula-Juchnowicz
November 26, 2020

Effects of Oat Fiber Intervention on Cognitive Behavior in LDLR-/- Mice Modeling Atherosclerosis by Targeting the Microbiome-Gut-Brain Axis

Journal of Agricultural and Food Chemistry
Hui GaoShufen Han
November 17, 2020
Review
Open Access

Therapeutic mechanisms of traditional Chinese medicine to improve metabolic diseases via the gut microbiota

Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie
Hai-Yu ZhangXiao-Lin Tong
November 15, 2020

Modulation of the Gut Microbiome and Obesity Biomarkers by Lactobacillus Plantarum KC28 in a Diet-Induced Obesity Murine Model

Probiotics and Antimicrobial Proteins
Eunchong HuangWilhelm Heinrich Holzapfel
November 21, 2020

The brain-gut axis - where are we now and how can we modulate these connections?

Current Neuropharmacology
Wojciech DabrowskiAndrzej K Siwicki
November 22, 2020
Comment / Editorial

Fishing for Irritable Bowel Syndrome: Which alarm features weave the best net?

Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
Justin Brandler, William D Chey
November 17, 2020
Open Access

Gut microbiota modulates expression of genes involved in the astrocyte-neuron lactate shuttle in the hippocampus

European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
Michael B MargineanuPierre J Magistretti
November 18, 2020
Preprint
Open Access

Retinitis Pigmentosa Is Associated With Shifts in The Gut Microbiome

ResearchSquare
Oksana KutsyrPedro Lax
November 24, 2020
Open Access

Methylmercury Interactions With Gut Microbiota and Potential Modulation of Neurogenic Niches in the Brain

Frontiers in Neuroscience
Daniel V PintoReinaldo B Oriá
November 24, 2020
Preprint
Open Access

Probiotics-induced changes in gut microbial composition and its effects on cognitive performance after stress.

MedRxiv : the Preprint Server for Health Sciences
Mirjam BloemendaalE. Aarts
November 21, 2020
Review
Open Access

Molecular Mechanisms of Microbiota-Mediated Pathology in Irritable Bowel Syndrome

International Journal of Molecular Sciences
Yoshiyuki Mishima, Shunji Ishihara
November 19, 2020

"Musings on the wanderer: What's new in our understanding of vago-vagal reflexes? VI. Central vagal circuits that control glucose metabolism."

American Journal of Physiology. Gastrointestinal and Liver Physiology
M Soledad Pitra, Bret N Smith
November 24, 2020

Dietary vitamin A supplementation prevents early obesogenic diet-induced microbiota, neuronal and cognitive alterations

International Journal of Obesity : Journal of the International Association for the Study of Obesity
Essi F BiyongGuillaume Ferreira

Sign up to follow this feed and discover related papers.

Related Feeds

3D Cellular Models of Brain and Neurodegeneration

Brain organoids are three-dimensional in vitro cellular models of the brain that can recapitulate many processes such as the microenvironment and neurodevelopment. In addition, these organoids can be combined with other cell types, such as neurons and astrocytes to study their interactions in assembloids. Disease processes can also be modelled by induced pluripotent stem cell derived organoids and assembloids from patients with neurodegenerative disorders. Discover the latest research here.

ALS

Amyotrophic lateral sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS & FTD: TDP-43

Amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) share a considerable proportion of characteristics including the same neuropathological substrate of abnormally phosphorylated TAR DNA binding protein (TDP-43). Here are the latest discoveries pertaining to ALS, FTD and TDP-43.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Pathogenic Mechanisms

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS: Phenotypes

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating phenotypes associated with this genetically heterogeneous disorder.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here are the latest discoveries pertaining to this disease.

ALS: Stress Granules

Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS therapies here.

Age-related Dementia

Age-related dementias present as cognitive decline that is not a part of normal aging. Age-related dementias include Alzheimer's disease, vascular dementia, and Lewy body dementia. Discover the latest research on age-related dementia here.

© 2020 Meta ULC. All rights reserved
/feed-previews/gut-microbiome-neurodegeneration/47ba9e17-13dd-49c8-a30e-a7c8c7d60b66